A study in evaluating the efficacy and safety of zonisamide and lamotrigine (Lamictal) for subjects with refractory simple partial, complex partial or partial with secondary generalized seizures.

Trial Profile

A study in evaluating the efficacy and safety of zonisamide and lamotrigine (Lamictal) for subjects with refractory simple partial, complex partial or partial with secondary generalized seizures.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 May 2017

At a glance

  • Drugs Zonisamide (Primary) ; Lamotrigine
  • Indications Complex partial epilepsy; Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 12 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Aug 2011 Actual initiation date changed from Feb 2006 to Mar 2006 as reported by ClinicalTrials.gov.
    • 12 Aug 2011 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top